# Controlled Study to Evaluate the Efficacy and Safety of the Treatment With Growth Hormone in Tibia Fractures

> **NCT00254514** · PHASE2 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 407 (actual)

## Conditions studied

- Bone Fracture
- Tibia Fractures

## Interventions

- **DRUG:** somatropin

## Key facts

- **NCT ID:** NCT00254514
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-08
- **Primary completion:** 2003-10
- **Final completion:** 2003-10
- **Target enrollment:** 407 (ACTUAL)
- **Last updated:** 2017-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00254514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00254514, "Controlled Study to Evaluate the Efficacy and Safety of the Treatment With Growth Hormone in Tibia Fractures". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00254514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*